Oncospace Inc. announces channel partner agreement with Xiel, Ltd.

Oncospace Inc. announces channel partner agreement with Xiel, Ltd. for the sale and distribution of Patient Data Conversion for Pinnacle™

Baltimore, January 30, 2024—Oncospace, Inc. today announced the following:

Oncospace has entered into an exclusive channel partnership agreement with Xiel, Ltd. for the sale and distribution of the Oncospace Patient Data Conversion for Pinnacle service in the United Kingdom and Ireland.

Since its establishment, Xiel, Ltd. has introduced cutting edge nuclear medicine, radiotherapy and diagnostic radiology solutions for healthcare professionals in the UK and Ireland. Oncospace is proud to be included in their esteemed portfolio of medical technology companies and products.

Learn more at: www.oncospace.com/why/pdc or www.xiel.co.uk.


All product and company names are trademarks ™ or registered ® trademarks of their respective holders. Use of these marks does not imply any affiliation with or endorsement by their respective holders.

ABOUT Xiel, Ltd.: Xiel is a specialist distributor of medical technologies in UK and Ireland. We work with global leading solution providers; therefore, continuously improving efficiency and quality for our customers. Our partners research and develop highly specific products for what is often a small world market. The expertise of Xiel lies in our deep understanding of the structure and organization of radiotherapy departments in the UK and Ireland, for us to advise on the best solutions possible.
For more information, please see our website – www.xiel.co.uk
Xiel. Exceptional Products. Extraordinary Service. Everyday.

ABOUT Oncospace, Inc.:  Oncospace attracts and best serves, lean, high-throughput radiation oncology clinics that share a vision of disrupting current radiotherapy planning conventions.  Together, we collaborate on AI-powered, data-driven, automation strategies that optimize outcomes for the patient and the practice.  Our cloud-native, data analytics platform is built with industry leading security and healthcare connectivity that leverages a customer’s existing investments in clinical software applications.  For more information, visit www.oncospace.com and follow us on LinkedIn:



Todd Deterding; Oncospace, Inc.


(443) 773-2271